Honoring the Heritage, Embracing the Future: Happy Singapore National Day!
Wishing you good health and a prosperous lunar new year!
Wishing you good health and a prosperous lunar new year!
Cell & Gene | 19 November 2024 | Analysis
Cell and gene therapy (CGT) is at the frontier of medical innovation, promising transformative solutions for s...Read more
Korea | 11 November 2024 | News
In a recent conversation with Ankit Kankar from BioSpectrum Asia, Yvonne Lungershausen, CEO of Avance Clinical...Read more
North America | 09 November 2024 | News
Trump’s Trade Tango Returns: Will China’s Biotech Dance Through Another Round of Tariffs or Stumble?
With Donald Trump’s return to the White House, the U.S.-China trade relationship is once again in the sp...Read more
North America | 06 November 2024 | News
EVŌQ Nano CEO Shaun Rothwell Discusses Advanced Antimicrobial Solution EVQ-218 and Its Impact on AMR
In an insightful interview with BioSpectrum Asia, Shaun Rothwell, CEO of EVŌQ Nano, reveals the transformative...Read more
Industry Insights | 05 November 2024 | Opinion
Pharma and Biotech Layoffs Signal Strategic Shift Towards Efficiency Amid Industry Restructuring
The current wave of layoffs across the pharmaceutical and biotech sectors, affecting major companies l...Read more
Bio LAB | 31 October 2024 | Company results
APAC Bullish on BioSupplier Revenue- Agilent
Agilent, USA Total revenue: $6,833 million APAC revenue: $1,383 million (China, including Hong Kong) ...Read more
Bio LAB | 31 October 2024 | Company results
APAC Bullish on BioSupplier Revenue- Eppendorf
Eppendorf SE, Germany Total revenue: $1,165 million (€1,081 million) APAC revenue: $356 million...Read more
Singapore | 18 October 2024 | News
BioSpectrum Asia sets the tone for Excellence Awards 2024 at Singapore on 6 December
To recognise and celebrate the remarkable achievements and contributions of Asian companies and individuals in...Read more
North America | 13 November 2024 | News
US-based ICU Medical, Inc., a worldwide leader in the development, manufacture and sale of innovative med...Read more
China | 26 September 2024 | News
Nuance Pharma expands distribution of nasal spray Bentrio in East and South East Asia
China-based Nuance Pharma has agreed with Altamira Medica, an associate company of Altamira Therapeutics ...Read more
Thailand | 23 September 2024 | News
Antengene receives approval to commercialise XPOVIO in Thailand for multiple myeloma patients
China-based Antengene Corporation has announced that the Thailand Food and Drug Administration has a...Read more
Singapore | 13 November 2024 | News
Scientists in Singapore use microcellular drones to deliver lung cancer-killing drugs
A team of researchers, led by Assistant Professor Minh Le from the Institute for Digital Medicine (WisDM) and ...Read more
Australia | 29 October 2024 | News
Australia's Vaxxas licenses next-gen vaccine for Respiratory Syncytial Virus from NIH
Australia-based Vaxxas, a clinical-stage biotechnology company commercialising a novel high-density micro...Read more
China | 10 October 2024 | News
China-based CanSino Biologics Inc. has received an additional financial boost, securing a grant exceeding $17 ...Read more
Singapore | 19 November 2024 | News
Singapore's SERI and Carl Zeiss invest SG$20 M for driving innovation in ophthalmic surgery
The Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec AG, one of the world's leading medical tech...Read more
Europe | 13 November 2024 | News
Korea's Lunit partners with VIDI group to deliver AI-powered mammography in France
South Korea-based Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagn...Read more
Korea | 16 October 2024 | News
Korean firms Neurophet & AriBio to develop next-gen platform for Alzheimer's diagnosis
South Korea-based startup Neurophet, an artificial intelligence (AI) solution company for brain disease, has a...Read more
Europe | 12 November 2024 | News
Lonza expands Bioconjugation capabilities with two additional manufacturing suites in Switzerland
Lonza, a global development and manufacturing partner to the pharmaceutical, biotech and nutraceutical markets...Read more
China | 29 October 2024 | News
China's WuXi Biologics launches WuXia RidGS for non-antibiotic cell line development
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (C...Read more
Korea | 01 October 2024 | News
SK pharmteco invests $260 M in Korea facility to expand global small molecule and peptide production
US-headquartered SK pharmteco, a global contract development and manufacturing organisation (CDMO), has announ...Read more
APAC Bullish on Biosupplier Revenue Amidst Global Uncertainty
The Asia-Pacific (APAC) market plays a crucial role for global biosupplier companies, contributing anywhere from 15 per cent to 25 per cent of their total global revenues. Between 2021 and 2023, the bioprocessing market was one of the strongest performers, growing at about 18 per cent annually due to COVID-19-driven demand. However, 2023 was a challenging year for biosuppliers, with the decline in COVID-19-related spending and various global events impacting business, resulting in plummeting revenue for most firms. While the bioprocessing sector saw impressive growth between 2021 and 2022, post-COVID-19 normalisation and rising financing costs have led to flat growth from 2022 to 2023. Despite this, the market is expected to rebound over the next two years, with an average growth forecast of around 9 per cent from 2023 to 2027, according to a report from Clearstate.
1 North Bridge Road,
#08-08 High Street Centre,
Singapore 179094
Email : communications@biospectrumasia.com
+65 90150305
